Table 2.

Male circumcision and HR-HPV viral DNA load in female partners.

	Intervention group		Control group		PRR (95% CI)*	adjPRR (95% CI)&
	High HR-HPV Viral Load* / N^	Percent (%)	High HR-HPV Viral Load* / N^	Percent (%)
Overall
Baseline	207/352	58.8%	210/338	62.1%	0.94 (0.83 - 1.07)	0.94 (0.83 - 1.06)
Year One	159/315	50.5%	188/353	53.3%	0.95 (0.82 - 1.11)	0.96 (0.82 - 1.12)
Year Two	99/232	42.7%	167/303	55.1%	0.78 (0.65 - 0.94)	0.80 (0.66 - 0.96)
Persistent HR-HPV
Year One	83/124	66.9%	85/119	71.4%	0.97 (0.83-1.13)	0.98 (0.84 - 1.14)
Year Two	50/73	68.5%	80/118	67.8%	1.02 (0.83 - 1.24)	1.04 (0.86 - 1.27)
Incident HR-HPV
Year One	76/191	39.8%	103/234	44.0%	0.91 (0.71 - 1.16)	0.94 (0.74 - 1.19)
Year Two	49/159	30.8%	87/185	47.0%	0.66 (0.50 - 0.87)	0.67 (0.50 - 0.89)

^*High HR-HPV viral load includes a linear array band signal strength of 3 or 4 which represents >200 copies/5μl.

^{^}N is the total number of genotypes detected.

^#PRR is a prevalence risk ratio.

^&adjPRR is an adjusted prevalence risk ratio. The multivariate analysis adjusted for age and number of sexual partners.